Home

The Best-in-Class Fully Human Antibody Mouse.

in situ V(D)J substitution Fully Human Variable Domain Murine Constant Region

RenMab™

Best-in-class fully human antibody discovery platform

Fully human heavy chain and kappa
light chain V(D)J loci substitution

RenLite®

Bispecific/multispecific antibody discovery platform

Fully human heavy chain repertoire combined with a light chain substitution

RenNano®

Heavy chain only antibody (HCAb) & nanobody discovery platform

Fully human heavy chain VDJ loci substitution with modified constant regions

RenMice® HiTS Platform

The RenMice® HiTS (Hyperimmune Target Specific) Platform consists of a library of RenMice® each with a specific target gene knocked out. These mice are designed to elicit robust immune responses against homologous proteins and generate antibodies that bind to broader epitopes.

Learn More
Search

BIOCYTOGEN & RENMAB COMMERCIAL BENEFITS

Licensing Options

License directly with Biocytogen
Option to use through other CROs or in-house

Co-development Opportunities

Exclusive partnership opportunities using our RenMice® HiTS Platform

Flexibility

Flexible terms tailored to accommodate different antibody programs